Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections, «CURRENT OPINION IN INFECTIOUS DISEASES», 2021, 34, pp. 737 - 747 [Scientific article]Open Access
Tiseo G.; Arena F.; Borre S.; Campanile F.; Falcone M.; Mussini C.; Pea F.; Sganga G.; Stefani S.; Venditti M., Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, 19, pp. 1373 - 1383 [Scientific article]Open Access
Cojutti P.G.; Gatti M.; Rinaldi M.; Tonetti T.; Laici C.; Mega C.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 781892 , pp. 1 - 11 [Scientific article]Open Access
Roberto Cairoli; Felicetto Ferrara; Corrado Girmenia; Mario Luppi; Federico Pea; Giorgina Specchia; Adriano Venditti, Management of patients with acute myeloid leukemia undergoing therapy with midostaurin: a focus on antifungal prophylaxis, «HEMATOLOGICAL ONCOLOGY», 2021, 39, pp. 20 - 26 [Scientific article]
Gatti M.; Pea F., Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors, «EXPERT REVIEW OF CLINICAL PHARMACOLOGY», 2021, 14, pp. 583 - 599 [Scientific article]
Rinaldi, Matteo; Cojutti, Pier Giorgio; Zamparini, Eleonora; Tedeschi, Sara; Rossi, Nicolò; Conti, Matteo; Giannella, Maddalena; Pea, Federico; Viale, Pierluigi, Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunction, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2021, 65, Article number: 02038-20 , pp. 1 - 33 [Scientific article]
Cojutti P.G.; Carnelutti A.; Lazzarotto D.; Sozio E.; Candoni A.; Fanin R.; Tascini C.; Pea F., Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles?, «PHARMACEUTICS», 2021, 13, Article number: 2099 , pp. 1 - 13 [Scientific article]Open Access
Cojutti P.G.; Morandin E.; Baraldo M.; Pea F., Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2021, 58, Article number: 106408 , pp. 1 - 9 [Scientific article]
Cojutti, Pier Giorgio; Rinaldi, Matteo; Zamparini, Eleonora; Rossi, Nicolò; Tedeschi, Sara; Conti, Matteo; Pea, Federico; Viale, Pierluigi, Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2021, 65, Article number: e02260-20 , pp. 1 - 12 [Scientific article]
Meschiari, Marianna; Volpi, Sara; Faltoni, Matteo; Dolci, Giovanni; Orlando, Gabriella; Franceschini, Erica; Menozzi, Marianna; Sarti, Mario; Del Fabro, Giovanni; Fumarola, Benedetta; Guarneri, Francesco; Lanza, Paola; Lorenzotti, Silvia; Saccani, Barbara; Signorini, Liana; Van Hauwermeiren, Evelyn; Gatti, Milo; Pea, Federico; Castelli, Francesco; Mussini, Cristina, Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections, «JAC-ANTIMICROBIAL RESISTANCE», 2021, 3, Article number: dlab188 , pp. 1 - 5 [Scientific article]Open Access
Cojutti, Pier Giorgio; Zanon, Ezio; Pasca, Samantha; Pea, Federico, Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency, «CLINICAL PHARMACOKINETICS», 2021, na, pp. 1 - 12 [Scientific article]
Gatti M.; Andreoni M.; Pea F.; Viale P., Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: A careful appraisal beyond approved indications focusing on unmet clinical needs, «DRUG DESIGN, DEVELOPMENT AND THERAPY», 2021, 15, pp. 3349 - 3378 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Should the Clinical Pharmacologist Play a Role in the Multidisciplinary Team Managing Severe Necrotizing Soft-Tissue Infections?, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 403 - 407 [Scientific article]
Gaibani, Paolo; Gatti, Milo; Rinaldi, Matteo; Crovara, Cristina; Lazzarotto, Tiziana; Giannella, Maddalena; Lombardo, Donatella; Amadesi, Stefano; Viale, Pierluigi; Pea, Federico; Ambretti, Simone, Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient, «INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES», 2021, 113, pp. 213 - 217 [Scientific article]Open Access
